Skip to main content
Equibles

Sofinnova Investments, Inc.

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1631134 Menlo Park, CA
Back to AVBP Full portfolio

Position in AVBP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$58,945,164
+$19,801,096 QoQ
Shares Held
1,696,752
0.0% QoQ
Ownership
3.44%
of shares outstanding
% of Portfolio
3.15%
of 13F equity value
Holder Rank
#9
of 158 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Sofinnova Investments, Inc. holds $1,182,454,857 across 43 Biotechnology names. AVBP ranks #6 (5.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VERA
Vera Therapeutics, Inc.
 2,793,987 $119,889,982
2 GMAB
Genmab A/S
 4,045,215 $111,122,056
3 JAZZ
Jazz Pharmaceuticals plc
 365,341 $88,036,220
4 RAPP
Rapport Therapeutics, Inc.
 1,904,408 $79,356,681
5 SPTX
Seaport Therapeutics, Inc.
 3,564,871 $77,428,998
6 AVBP
ArriVent BioPharma, Inc.
This page 		1,696,752 $58,945,164
7 RARE
Ultragenyx Pharmaceutical Inc.
 1,717,505 $57,347,491
8 RYTM
Rhythm Pharmaceuticals, Inc.
 408,027 $45,303,237

All Filings in AVBP

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $58,945,164 1,696,752
2026-03-31 $39,144,068 1,696,752
2025-12-31 $34,138,650 1,696,752
2025-09-30 $31,305,074 1,696,752
2025-06-30 $36,938,291 1,696,752
2025-03-31 $31,372,944 1,696,752
2024-12-31 $45,201,473 1,696,752
2024-09-30 $39,873,672 1,696,752
2024-06-30 $31,474,749 1,696,752
2024-03-31 $30,303,990 1,696,752